Comparison of Intramuscular and Oral Vitamin D Treatment in Preterm Infants

Comparison of vitamin D levels after oral and intramascular vitamin D treatment in premature infants with vitamin D deficiency

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20160120026115N8

Enrollment

Registered

2022-02-26

Start date

2020-11-21

Completion date

Unknown

Last updated

2022-03-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vitamin D deficiency. Vitamin D deficiency, unspecified

Interventions

Intervention 1: Intervention group: Intramuscular injection of vitamin D( injection 15000 units per day single dose). Intervention 2: Control group: Prescribing oral vitamin D (oral drops of 1000 unit

Eligibility

Sex/Gender

All

Age

14 Days to 28 Days

Inclusion criteria

Inclusion criteria: All premature infants in the NICU ward Vitamin D level within the range of deficiency.

Exclusion criteria

Exclusion criteria: Premature infants who received oral or intravenous administration of vitamin D before the start of the study neonates have a malabsorption disease based on clinical presentation neonates with GFR less than 50 neonates with thyroid disorders

Design outcomes

Primary

Measure	Time frame
Serum level in terms of vitamin D. Timepoint: At the beginning of the study and 14 days after treatment. Method of measurement: Lab tests.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMandana Kashaki

Iran University of Medical Sciences

kashakimd@gmail.com+98 21 5560 6034

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026